translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
Clinical Trials of New Anti-AIDS Drug Begin

June 21, 1989
United Press International (06/21/89)

Los Angeles--Clinical trials of AZDU--a drug researchers hope will attack HIV and be less toxic than AZT--are underway. The Food and Drug Administration recently gave Triton Biosciences Inc. of Alameda, Calif., approval to evaluate the drug's effectiveness in HIV-infected individuals. The drug maker is conducting studies in conjunction with UCLA researchers. In addition to the trials at UCLA's AIDS Clinical Research Center, the National Institute of Allergy and Infectious Diseases has started a first phase safety and tolerance tests. In animal studies, the new drug was less toxic than AZT. AZDU disrupts HIV replication in infected cells.